Effect of interstitial chemotherapy of PLGA-gemcitabine microsphere on pancreatic cancer
Li Jingquan,Zhao Ping,Wang Shiliang,Wang Zheng,Li Aidong,Zhang Yongming,Han Zhikai,Ma Jie
DOI: https://doi.org/10.3969/j.issn.1672-1535.2008.06.012
2008-01-01
Abstract:Objective To study the antitumor effect of slow-release PLGA(polylactic-co-glycolic acid)-gem- citabine microsphere on xenograft pancreatic tumor in mice.Methods Totally 80 tumor-bearing nude mice were randomly divided into eight groups for different treatments.Group A1,A2,and A3 were trea- ted with intratumoral injection of PLGA-gemcitabine microsphere,and the doses of gemcitabine were 5mg/ kg,2.5mg/kg,and 1.25mg/kg,respectively.Group B was treated with intratumoral gemcitabine injec- tion,and the dose was 5 mg/kg.Group C was treated with abdominal cavity injection of gemcitabine, and the dose was 5 mg/kg.Group D was treated with intratumoral injection of PLGA-5-Fu microsphere, and the dose of 5-Fu was 5mg/kg.Group E was treated with intratumoral injection of PLGA,and the dose was 5 mg/kg;Group F did not receive any treatment.On the days of 0 and 4,8,12,16,20, 24 after the drug injection,health condition and body mass was weighed,the size of the tumor were ob- served,and the growth curve was drawn.At the end of the experiment,the weight of the tumor was measured and tumor inhibiting rate was calculated,and the tumor expression of VEGF was measured in group A1,A2,A3 and F.Results Tumor inhibiting rate of group A1 and A2 were 66% and 40% re- spectively,and there were statistical differences between groups A1,A2 and other groups(P<0.05). Expression of VEGF decreased follow the dose increase of PLGA-Gemcitabine microsphere,there were statistical differences between A1,A2 and F groups(P<0.05).The weight changed before and after treatment in every group had no statistical differences.Conclusion Interstitial chemotherapy of PLGA- gemcitabine microsphere can effectively reduce the expression of VEGF and restrain the tumor growth.PL- GA-gemcitabine microsphere has no evident side effects and is clinically beneficial.